Hospital Acquired Infections (HAI) Diagnostics Market, Global Outlook and Forecast 2022-2028
Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.
This report contains market size and forecasts of Hospital Acquired Infections (HAI) Diagnostics in Global, including the following market information:
Global Hospital Acquired Infections (HAI) Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital Acquired Infections (HAI) Diagnostics market was valued at 3428.4 million in 2021 and is projected to reach US$ 4532.7 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Diagnostics Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital Acquired Infections (HAI) Diagnostics include BioM?rieux, Abbott Laboratories, Roche AG and Siemens Healthcare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Acquired Infections (HAI) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Acquired Infections (HAI) Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, by Type, 2021 (%)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, by Application, 2021 (%)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Hospital Acquired Infections (HAI) Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hospital Acquired Infections (HAI) Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Hospital Acquired Infections (HAI) Diagnostics in Global, including the following market information:
Global Hospital Acquired Infections (HAI) Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital Acquired Infections (HAI) Diagnostics market was valued at 3428.4 million in 2021 and is projected to reach US$ 4532.7 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Diagnostics Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital Acquired Infections (HAI) Diagnostics include BioM?rieux, Abbott Laboratories, Roche AG and Siemens Healthcare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Acquired Infections (HAI) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Acquired Infections (HAI) Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, by Type, 2021 (%)
- Molecular Diagnostics Tests
- Other In-vitro Diagnostic Tests
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Bloodstream Infections (BSI)
- Urinary Tract Infections (UTI)
- Surgical Site Infections (SSI)
- Pneumonia
- Others
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Hospital Acquired Infections (HAI) Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hospital Acquired Infections (HAI) Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- BioM?rieux
- Abbott Laboratories
- Roche AG
- Siemens Healthcare
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Hospital Acquired Infections (HAI) Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Acquired Infections (HAI) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HOSPITAL ACQUIRED INFECTIONS (HAI) DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size: 2021 VS 2028
2.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Hospital Acquired Infections (HAI) Diagnostics Players in Global Market
3.2 Top Global Hospital Acquired Infections (HAI) Diagnostics Companies Ranked by Revenue
3.3 Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Hospital Acquired Infections (HAI) Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hospital Acquired Infections (HAI) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Hospital Acquired Infections (HAI) Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Hospital Acquired Infections (HAI) Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Molecular Diagnostics Tests
4.1.3 Other In-vitro Diagnostic Tests
4.2 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Market Size, 2021 & 2028
5.1.2 Bloodstream Infections (BSI)
5.1.3 Urinary Tract Infections (UTI)
5.1.4 Surgical Site Infections (SSI)
5.1.5 Pneumonia
5.1.6 Others
5.2 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.3.2 US Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.3.3 Canada Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.3.4 Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.4.2 Germany Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.3 France Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.4 U.K. Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.5 Italy Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.6 Russia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.8 Benelux Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.5.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5.3 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5.4 South Korea Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5.6 India Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.6.2 Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.6.3 Argentina Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.7.2 Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.7.3 Israel Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.7.5 UAE Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 BioM?rieux
7.1.1 BioM?rieux Corporate Summary
7.1.2 BioM?rieux Business Overview
7.1.3 BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.1.4 BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2017-2022)
7.1.5 BioM?rieux Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.2.4 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Abbott Laboratories Key News
7.3 Roche AG
7.3.1 Roche AG Corporate Summary
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.3.4 Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Roche AG Key News
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Corporate Summary
7.4.2 Siemens Healthcare Business Overview
7.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.4.4 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Siemens Healthcare Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Hospital Acquired Infections (HAI) Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Acquired Infections (HAI) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HOSPITAL ACQUIRED INFECTIONS (HAI) DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size: 2021 VS 2028
2.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Hospital Acquired Infections (HAI) Diagnostics Players in Global Market
3.2 Top Global Hospital Acquired Infections (HAI) Diagnostics Companies Ranked by Revenue
3.3 Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Hospital Acquired Infections (HAI) Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hospital Acquired Infections (HAI) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Hospital Acquired Infections (HAI) Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Hospital Acquired Infections (HAI) Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Molecular Diagnostics Tests
4.1.3 Other In-vitro Diagnostic Tests
4.2 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Market Size, 2021 & 2028
5.1.2 Bloodstream Infections (BSI)
5.1.3 Urinary Tract Infections (UTI)
5.1.4 Surgical Site Infections (SSI)
5.1.5 Pneumonia
5.1.6 Others
5.2 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.3.2 US Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.3.3 Canada Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.3.4 Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.4.2 Germany Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.3 France Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.4 U.K. Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.5 Italy Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.6 Russia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.4.8 Benelux Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.5.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5.3 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5.4 South Korea Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.5.6 India Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.6.2 Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.6.3 Argentina Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028
6.7.2 Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.7.3 Israel Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
6.7.5 UAE Hospital Acquired Infections (HAI) Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 BioM?rieux
7.1.1 BioM?rieux Corporate Summary
7.1.2 BioM?rieux Business Overview
7.1.3 BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.1.4 BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2017-2022)
7.1.5 BioM?rieux Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.2.4 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Abbott Laboratories Key News
7.3 Roche AG
7.3.1 Roche AG Corporate Summary
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.3.4 Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Roche AG Key News
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Corporate Summary
7.4.2 Siemens Healthcare Business Overview
7.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Major Product Offerings
7.4.4 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Siemens Healthcare Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Hospital Acquired Infections (HAI) Diagnostics Market Opportunities & Trends in Global Market
Table 2. Hospital Acquired Infections (HAI) Diagnostics Market Drivers in Global Market
Table 3. Hospital Acquired Infections (HAI) Diagnostics Market Restraints in Global Market
Table 4. Key Players of Hospital Acquired Infections (HAI) Diagnostics in Global Market
Table 5. Top Hospital Acquired Infections (HAI) Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hospital Acquired Infections (HAI) Diagnostics Product Type
Table 9. List of Global Tier 1 Hospital Acquired Infections (HAI) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. BioM?rieux Corporate Summary
Table 31. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 32. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 35. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Roche AG Corporate Summary
Table 37. Roche AG Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 38. Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Siemens Healthcare Corporate Summary
Table 40. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 41. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 1. Hospital Acquired Infections (HAI) Diagnostics Market Opportunities & Trends in Global Market
Table 2. Hospital Acquired Infections (HAI) Diagnostics Market Drivers in Global Market
Table 3. Hospital Acquired Infections (HAI) Diagnostics Market Restraints in Global Market
Table 4. Key Players of Hospital Acquired Infections (HAI) Diagnostics in Global Market
Table 5. Top Hospital Acquired Infections (HAI) Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hospital Acquired Infections (HAI) Diagnostics Product Type
Table 9. List of Global Tier 1 Hospital Acquired Infections (HAI) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hospital Acquired Infections (HAI) Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. BioM?rieux Corporate Summary
Table 31. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 32. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 35. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Roche AG Corporate Summary
Table 37. Roche AG Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 38. Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Siemens Healthcare Corporate Summary
Table 40. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product Offerings
Table 41. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Hospital Acquired Infections (HAI) Diagnostics Segment by Type in 2021
Figure 2. Hospital Acquired Infections (HAI) Diagnostics Segment by Application in 2021
Figure 3. Global Hospital Acquired Infections (HAI) Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2021
Figure 8. By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Hospital Acquired Infections (HAI) Diagnostics Segment by Type in 2021
Figure 2. Hospital Acquired Infections (HAI) Diagnostics Segment by Application in 2021
Figure 3. Global Hospital Acquired Infections (HAI) Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2021
Figure 8. By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hospital Acquired Infections (HAI) Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. BioM?rieux Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche AG Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
